Methscopolamine Bromide USP (USDMF-29805)
Decades ago, a Company embarked on the journey to understand the twin benefits of a meaningful combination of medicine and nutrition. That Company - Alchem International Ltd, which started making a significant impact years ago, has firmly arrived, with an array of nutraceutical products, duly acknowledged and widely accepted.
The processes, intensive research, planned investment, integrated capabilities, value additions through bio-technology, semi-synthesis, foot prints in the formulation space, directional progression and commitment to the cause has given the nutraceutical products of Alchem International Ltd deserved respect by the international community.
The production facilities have US FDA, EU GMP and WHO accreditations. Total commitment to quality drives the Company to its settled goals. Work towards growth resonates through the Company.
Alchem International with 75 years of experience in the phytochemical space has been diligently providing plant derived ingredients, active pharmaceutical ingredients and bulk drugs to all international significant geographies and the Company’s interest in skin care is logical to its dimensional growth.
Sheer Quality drives Alchem’s operations
Through perfect blend of science and nature, dedicated research, selection of finest botanical herbal extracts and focused technology, Alchem has successfully extracted the potent active molecules in the plant and offers it for nutraceutical use to help various companies spread wellness.
Methylscopolamine bromide
"For pharmaceutical use, Alchem offers Methylscopolamine bromide with all its inherent benefits"
Scopolamine or hyoscine is a tropane alkaloid drug with muscarinic antagonist effects. It is among the secondary metabolites of plants from Solanaceae (nightshade) family of plants, such as henbane, jimson weed (Datura), angel's trumpets (Brugmansia), and corkwood (Duboisia). Methscopolamine, a methylated derivative of scopolamine, is a muscarinic antagonist that belongs to a class of drugs known as anticholinergics.
Methscopolamine bromide is structurally similar to the neurotransmitter acetylcholine and acts by blocking the muscarinic acetylcholine receptors. It is a muscarinic antagonist that exerts anticholinergic effects which include reducing the volume and total acid content of gastric secretion, inhibiting gastrointestinal motility and salivary secretion, dilation of the pupil and blocking accommodation that results in blurring of vision.
Methscopolamine bromide is used along with other medications to treat peptic ulcers by reducing stomach acid secretion. It can also be used for stomach or intestinal spasms, to reduce salivation, and to treat motion sickness. Methscopolamine is also commonly used as a drying agent, to dry up post-nasal drip, in cold, irritable bowel syndrome and allergy medications.
The product addresses broad spectrum physiological concerns and has the band width and capabilities to meet expectations. Regular use should exhibit demonstrable results to inhibit various health related issues.
